Genesco’s (NYSE:GCO) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Genesco (GCO) reported Q2 CY2026 revenue of $529.9M, down 3% YoY but in line with expectations. Non-GAAP loss per share was $0.83, better than estimates. CEO Mimi Vaughn cited strategic actions for sales decline and expressed confidence in future growth. Analysts expect flat revenue growth over the next 12 months.

Original reporting
Published Sep 3, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 12:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Genesco’s (NYSE:GCO) Q2 CY2026 Earnings Results: Revenue In Line With Expectations — source image
Decision brief

The 30-second read

$GCONeutralMed
01

Why it matters

The earnings release provides fresh financial metrics and modest price reaction, informing short‑term trading decisions.

02

Market read

First‑report Q2 earnings for Genesco, a consumer discretionary mid‑cap, with modest beat and flat outlook.

03

What to watch

Store closures and license transitions may improve margins long‑term, offering upside if execution succeeds.

Relevance 8/10Novelty 8/10Timing: post‑market

Background

Genesco is a mid‑cap footwear and apparel retailer with brands Journeys, Johnston & Murphy, and Schuh.

Company-level read

Ticker impact

$GCONeutralHigh confidence
Context

Genesco reported Q2 CY2026 revenue in line with expectations but a 3% YoY decline and a non‑GAAP loss of $0.83 per share, beating EPS estimates.

Expected impact

Potential short‑term rally limited to 2‑3% as investors digest modest beat and guidance miss.

Evidence & confidence

First‑report earnings provide fresh data; beat on EPS but guidance below expectations limits bullish case.

Market effects

Consumer discretionary footwear segment may face pressure as Genesco signals flat revenue outlook.

U.S. retail investors may adjust exposure to mid‑cap apparel stocks.

Limited; primarily affects U.S. consumer discretionary equities.

Counterpoint

Despite earnings beat, flat revenue and weak guidance could signal deeper demand issues, suggesting a short bias.

Key entities

  • Mimi E. Vaughn

    Board Chair, President and CEO of Genesco.

Related articles

$GCOHigh

Genesco Boosts FY27 Adj. EPS Outlook As Q2 Swings To Profit

Genesco (GCO) reported Q2 net earnings of $3.48M ($0.32/share), reversing last year's loss. It raised FY27 adjusted EPS guidance to $2.00-$2.30/share, down from $2.00-$2.40, on lower sales expectations. Q2 sales declined 3% to $529.86M, with comparable sales down 1%. GCO shares rose 2.95% in premarket trading.

$GCOHigh

GENESCO INC (GCO): Results of Operations and Financial Condition

GENESCO INC (GCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 GENESCO INC. REPORTS FISCAL 2027 SECOND QUARTER RESULTS --Operating Income and EPS Improvement Exceed Expectations and Last Year-- -- Journeys Comparable Sales +2%, Johnston & Murphy Comparable Sales +4%-- --Eighth Consecutive Quarter of Positive Total Comparable Sal

$GCOHighAI 9/10

Genesco (NYSE:GCO) Issues Earnings Results

Genesco (NYSE:GCO) reported quarterly EPS of -$2.18, beating analysts’ -$2.58 consensus by $0.40, on revenue of $487.03M vs. $474.33M expected, according to FiscalAI. The company updated FY2027 EPS guidance to $2.00–$2.40 and said Journeys comps rose 5% and Johnston & Murphy comps rose 7%, while Schuh comps fell 9%.

$GCOMedAI 9/10

Benzinga

Genesco (NYSE:GCO) reported a narrower first-quarter adjusted loss of $2.18 per share versus the expected $2.56, with revenue up 3% to $487.0 million (above $475.0 million consensus). Comparable sales rose 2% (store +3%, e-commerce flat); gross margin rose 30 bps. The company expects $23–$25 million in tariff refunds and $40–$50 million cost savings through fiscal 2029, and raised fiscal 2027 adjusted EPS guidance to $2.00–$2.40. Shares were up 4.37% to $37.97.